Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hnf1b
|
ENSMUSG00000020679.5 | Hnf1b |
Gene | Promoter | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Hnf1b | chr11_83881542_83881717 | 28669 | 0.123794 | 0.95 | 4.3e-03 | Click! |
Hnf1b | chr11_83885273_83885445 | 32399 | 0.117812 | 0.91 | 1.1e-02 | Click! |
Hnf1b | chr11_83852736_83852913 | 136 | 0.944620 | 0.91 | 1.2e-02 | Click! |
Hnf1b | chr11_83849884_83850450 | 104 | 0.897137 | -0.89 | 1.8e-02 | Click! |
Hnf1b | chr11_83882251_83882421 | 29376 | 0.122684 | 0.80 | 5.7e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_42112143_42112724 | 16.64 |
Gm14615 |
predicted gene 14615 |
18290 |
0.16 |
chr1_164471743_164471894 | 14.31 |
Gm32391 |
predicted gene, 32391 |
9376 |
0.14 |
chr12_25132144_25132315 | 14.13 |
Gm17746 |
predicted gene, 17746 |
3055 |
0.22 |
chr19_55505247_55505422 | 13.39 |
Vti1a |
vesicle transport through interaction with t-SNAREs 1A |
124320 |
0.06 |
chr15_82290409_82290560 | 12.84 |
Septin3 |
septin 3 |
6054 |
0.09 |
chr11_16704048_16704199 | 12.28 |
Gm25698 |
predicted gene, 25698 |
28588 |
0.15 |
chr7_100937600_100937760 | 11.51 |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
5573 |
0.15 |
chr6_28891682_28891856 | 11.14 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
11726 |
0.21 |
chr10_33814374_33814533 | 11.02 |
Gm10327 |
predicted pseudogene 10327 |
4955 |
0.17 |
chr2_155539663_155540189 | 10.76 |
Mipep-ps |
mitochondrial intermediate peptidase, pseudogene |
2721 |
0.13 |
chr1_88976364_88976553 | 10.65 |
1700067G17Rik |
RIKEN cDNA 1700067G17 gene |
39655 |
0.14 |
chr12_88652476_88652666 | 10.54 |
1700040E09Rik |
RIKEN cDNA 1700040E09 gene |
20302 |
0.14 |
chr10_12278450_12278601 | 10.32 |
Gm48723 |
predicted gene, 48723 |
46136 |
0.14 |
chrX_15753761_15753939 | 10.09 |
Gm22464 |
predicted gene, 22464 |
46068 |
0.17 |
chr4_62508801_62509208 | 9.84 |
Hdhd3 |
haloacid dehalogenase-like hydrolase domain containing 3 |
5537 |
0.12 |
chr11_83852736_83852913 | 9.76 |
Hnf1b |
HNF1 homeobox B |
136 |
0.94 |
chr11_85618066_85618217 | 9.63 |
Bcas3 |
breast carcinoma amplified sequence 3 |
22563 |
0.21 |
chr16_22698076_22698372 | 9.44 |
Gm8118 |
predicted gene 8118 |
12030 |
0.18 |
chr14_45452880_45453061 | 9.33 |
Gm34250 |
predicted gene, 34250 |
5897 |
0.13 |
chr6_100452431_100452603 | 8.95 |
Gm23234 |
predicted gene, 23234 |
42297 |
0.14 |
chr7_139559759_139559933 | 8.94 |
Nkx6-2 |
NK6 homeobox 2 |
22944 |
0.17 |
chr13_59498313_59498500 | 8.86 |
Agtpbp1 |
ATP/GTP binding protein 1 |
15748 |
0.16 |
chr8_126737026_126737184 | 8.72 |
Gm45805 |
predicted gene 45805 |
21229 |
0.23 |
chr8_108101452_108101603 | 8.65 |
Zfhx3 |
zinc finger homeobox 3 |
106968 |
0.07 |
chr5_117293923_117294074 | 8.55 |
Gm3786 |
predicted gene 3786 |
408 |
0.73 |
chr6_99145207_99145385 | 8.47 |
Foxp1 |
forkhead box P1 |
17722 |
0.26 |
chr18_31581248_31581399 | 8.45 |
B930094E09Rik |
RIKEN cDNA B930094E09 gene |
28189 |
0.14 |
chr6_108632476_108632647 | 8.36 |
0610040F04Rik |
RIKEN cDNA 0610040F04 gene |
18566 |
0.14 |
chr15_10713141_10713319 | 8.34 |
Rai14 |
retinoic acid induced 14 |
310 |
0.87 |
chr2_174818226_174818391 | 8.25 |
Gm14617 |
predicted gene 14617 |
20326 |
0.16 |
chr14_78850607_78850779 | 7.98 |
Vwa8 |
von Willebrand factor A domain containing 8 |
1439 |
0.39 |
chr5_104399237_104399791 | 7.98 |
Spp1 |
secreted phosphoprotein 1 |
35604 |
0.12 |
chr12_114053283_114053753 | 7.95 |
Ighv3-2 |
immunoglobulin heavy variable 3-2 |
19285 |
0.13 |
chr8_33987157_33987321 | 7.89 |
Gm45817 |
predicted gene 45817 |
39 |
0.96 |
chr5_49344702_49344867 | 7.85 |
Kcnip4 |
Kv channel interacting protein 4 |
59125 |
0.1 |
chr13_10396493_10396672 | 7.84 |
Chrm3 |
cholinergic receptor, muscarinic 3, cardiac |
35735 |
0.17 |
chr18_36527710_36528079 | 7.79 |
Slc4a9 |
solute carrier family 4, sodium bicarbonate cotransporter, member 9 |
253 |
0.88 |
chr8_4314973_4315142 | 7.79 |
Elavl1 |
ELAV (embryonic lethal, abnormal vision)-like 1 (Hu antigen R) |
438 |
0.72 |
chr19_27672733_27673067 | 7.77 |
Gm24782 |
predicted gene, 24782 |
31107 |
0.23 |
chr9_60315654_60315805 | 7.76 |
2010001M07Rik |
RIKEN cDNA 2010001M07 gene |
18413 |
0.22 |
chr4_55014920_55015072 | 7.75 |
Zfp462 |
zinc finger protein 462 |
3516 |
0.32 |
chr19_20633935_20634119 | 7.67 |
Aldh1a1 |
aldehyde dehydrogenase family 1, subfamily A1 |
32066 |
0.18 |
chr6_50363496_50363647 | 7.58 |
Osbpl3 |
oxysterol binding protein-like 3 |
6644 |
0.27 |
chrX_85878378_85878579 | 7.54 |
5430427O19Rik |
RIKEN cDNA 5430427O19 gene |
8124 |
0.2 |
chr7_97622705_97622904 | 7.51 |
Rsf1os1 |
remodeling and spacing factor 1, opposite strand 1 |
22308 |
0.1 |
chr2_126622639_126622795 | 7.39 |
Hdc |
histidine decarboxylase |
3418 |
0.2 |
chr7_115684191_115684500 | 7.37 |
Sox6 |
SRY (sex determining region Y)-box 6 |
21980 |
0.28 |
chr13_111818630_111818791 | 7.37 |
Gm15327 |
predicted gene 15327 |
8242 |
0.14 |
chr9_61306359_61306512 | 7.36 |
B930092H01Rik |
RIKEN cDNA B930092H01 gene |
12626 |
0.21 |
chr2_146577293_146577459 | 7.34 |
4933406D12Rik |
RIKEN cDNA 4933406D12 gene |
34445 |
0.2 |
chr8_34455567_34455746 | 7.30 |
Gm45349 |
predicted gene 45349 |
17339 |
0.17 |
chr10_115809219_115809409 | 7.26 |
Tspan8 |
tetraspanin 8 |
7518 |
0.27 |
chr14_12073823_12073990 | 7.24 |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
17254 |
0.23 |
chr9_37082260_37082465 | 7.23 |
Pknox2 |
Pbx/knotted 1 homeobox 2 |
917 |
0.53 |
chr10_71181938_71182201 | 7.22 |
C730027H18Rik |
RIKEN cDNA C730027H18 gene |
17 |
0.93 |
chr5_90518764_90518951 | 7.21 |
Afm |
afamin |
75 |
0.95 |
chr11_111605518_111605669 | 7.20 |
Gm11676 |
predicted gene 11676 |
7713 |
0.32 |
chr7_130015298_130015740 | 7.19 |
Gm23847 |
predicted gene, 23847 |
19575 |
0.24 |
chr16_36545463_36545634 | 7.16 |
Casr |
calcium-sensing receptor |
16058 |
0.11 |
chr10_79814404_79814832 | 7.14 |
Palm |
paralemmin |
44 |
0.93 |
chr1_156057714_156057966 | 7.11 |
Tor1aip2 |
torsin A interacting protein 2 |
5373 |
0.18 |
chr1_105115490_105115660 | 7.09 |
Gm29012 |
predicted gene 29012 |
879 |
0.71 |
chr17_43275309_43275499 | 7.06 |
Adgrf1 |
adhesion G protein-coupled receptor F1 |
5075 |
0.29 |
chr4_129320984_129321142 | 7.04 |
Rbbp4 |
retinoblastoma binding protein 4, chromatin remodeling factor |
13581 |
0.11 |
chr1_137195226_137195377 | 6.95 |
Gm25609 |
predicted gene, 25609 |
20346 |
0.22 |
chr8_111739071_111739223 | 6.95 |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
4662 |
0.21 |
chr16_90402615_90402775 | 6.93 |
Hunk |
hormonally upregulated Neu-associated kinase |
2151 |
0.29 |
chr9_63201496_63201967 | 6.93 |
Skor1 |
SKI family transcriptional corepressor 1 |
52770 |
0.12 |
chr7_3145683_3146014 | 6.88 |
Gm29708 |
predicted gene, 29708 |
4143 |
0.09 |
chr12_24686459_24686655 | 6.84 |
Cys1 |
cystin 1 |
4744 |
0.16 |
chr1_51467935_51468124 | 6.84 |
Nabp1 |
nucleic acid binding protein 1 |
5367 |
0.2 |
chr9_70720929_70721093 | 6.80 |
Adam10 |
a disintegrin and metallopeptidase domain 10 |
41995 |
0.13 |
chr10_95124544_95124708 | 6.78 |
Gm48868 |
predicted gene, 48868 |
8247 |
0.16 |
chr4_101714285_101714468 | 6.78 |
Lepr |
leptin receptor |
3028 |
0.31 |
chr16_38521173_38521530 | 6.70 |
Timmdc1 |
translocase of inner mitochondrial membrane domain containing 1 |
1290 |
0.33 |
chr2_119566293_119566470 | 6.69 |
Chp1 |
calcineurin-like EF hand protein 1 |
224 |
0.89 |
chr16_86808963_86809164 | 6.63 |
Gm32461 |
predicted gene, 32461 |
2550 |
0.28 |
chr10_96077598_96077752 | 6.61 |
Gm49817 |
predicted gene, 49817 |
18330 |
0.18 |
chr3_98044919_98045386 | 6.60 |
Gm42819 |
predicted gene 42819 |
14465 |
0.18 |
chr12_117720585_117720755 | 6.60 |
Gm18955 |
predicted gene, 18955 |
3302 |
0.28 |
chr9_13681735_13681905 | 6.59 |
Maml2 |
mastermind like transcriptional coactivator 2 |
19360 |
0.18 |
chr12_55904956_55905107 | 6.58 |
Gm22296 |
predicted gene, 22296 |
5892 |
0.22 |
chr6_35273676_35273858 | 6.57 |
Slc13a4 |
solute carrier family 13 (sodium/sulfate symporters), member 4 |
14407 |
0.14 |
chr1_64859919_64860180 | 6.56 |
Plekhm3 |
pleckstrin homology domain containing, family M, member 3 |
23285 |
0.18 |
chr12_57444292_57444465 | 6.56 |
Gm16246 |
predicted gene 16246 |
5742 |
0.24 |
chr3_37938233_37938565 | 6.54 |
Gm7799 |
predicted gene 7799 |
21688 |
0.15 |
chr16_32427729_32427880 | 6.53 |
Pcyt1a |
phosphate cytidylyltransferase 1, choline, alpha isoform |
3117 |
0.15 |
chr2_155894374_155894540 | 6.51 |
Uqcc1 |
ubiquinol-cytochrome c reductase complex assembly factor 1 |
16147 |
0.11 |
chr4_150909412_150909588 | 6.51 |
Park7 |
Parkinson disease (autosomal recessive, early onset) 7 |
17 |
0.97 |
chr2_5563520_5563967 | 6.50 |
Gm13216 |
predicted gene 13216 |
39828 |
0.19 |
chr10_21459651_21460332 | 6.50 |
Gm48386 |
predicted gene, 48386 |
14355 |
0.15 |
chr11_67108073_67108249 | 6.48 |
Mir6923 |
microRNA 6923 |
8357 |
0.13 |
chr19_55096698_55097015 | 6.44 |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
2595 |
0.27 |
chr13_98684591_98684906 | 6.43 |
Tmem171 |
transmembrane protein 171 |
10020 |
0.14 |
chr18_39827979_39828276 | 6.43 |
Pabpc2 |
poly(A) binding protein, cytoplasmic 2 |
54630 |
0.14 |
chr17_77734723_77734890 | 6.42 |
Gm4711 |
predicted gene 4711 |
47457 |
0.17 |
chr11_50186351_50186511 | 6.39 |
Mrnip |
MRN complex interacting protein |
11524 |
0.1 |
chr2_133768533_133768854 | 6.36 |
Gm25258 |
predicted gene, 25258 |
184272 |
0.03 |
chr12_79950821_79950997 | 6.34 |
Gm5654 |
predicted gene 5654 |
11270 |
0.18 |
chr1_136966814_136966973 | 6.34 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
6445 |
0.23 |
chr11_50354656_50355246 | 6.33 |
Cby3 |
chibby family member 3 |
489 |
0.68 |
chr8_115089778_115090403 | 6.30 |
Gm22556 |
predicted gene, 22556 |
37177 |
0.23 |
chr6_128538055_128538238 | 6.29 |
A2ml1 |
alpha-2-macroglobulin like 1 |
5348 |
0.1 |
chr4_144957116_144957269 | 6.28 |
Gm38074 |
predicted gene, 38074 |
1656 |
0.38 |
chr2_137156125_137156303 | 6.27 |
Jag1 |
jagged 1 |
39570 |
0.17 |
chr3_147847635_147847786 | 6.26 |
Gm36888 |
predicted gene, 36888 |
212063 |
0.02 |
chr4_155566693_155567032 | 6.22 |
Nadk |
NAD kinase |
2790 |
0.15 |
chr2_107964784_107964946 | 6.22 |
Gm23439 |
predicted gene, 23439 |
78226 |
0.11 |
chrX_93028340_93028492 | 6.15 |
Gm24973 |
predicted gene, 24973 |
39221 |
0.19 |
chr13_90463528_90463692 | 6.12 |
Gm47520 |
predicted gene, 47520 |
45510 |
0.16 |
chr18_14484868_14485021 | 6.10 |
Gm50098 |
predicted gene, 50098 |
7061 |
0.24 |
chr9_95554354_95554511 | 6.09 |
Gm32281 |
predicted gene, 32281 |
65 |
0.96 |
chr19_55700999_55701186 | 6.08 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
40728 |
0.21 |
chr2_101827717_101827895 | 6.07 |
Prr5l |
proline rich 5 like |
11174 |
0.22 |
chr7_16604272_16604437 | 6.06 |
Gm29443 |
predicted gene 29443 |
9470 |
0.09 |
chr4_107899351_107899556 | 6.04 |
Czib |
CXXC motif containing zinc binding protein |
6083 |
0.13 |
chr1_4597988_4598139 | 6.02 |
Gm37323 |
predicted gene, 37323 |
11811 |
0.14 |
chr1_91101809_91101972 | 6.02 |
Lrrfip1 |
leucine rich repeat (in FLII) interacting protein 1 |
9324 |
0.19 |
chr6_58639597_58639761 | 5.99 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
867 |
0.66 |
chr8_115536972_115537139 | 5.98 |
4930488N15Rik |
RIKEN cDNA 4930488N15 gene |
48337 |
0.16 |
chr4_45967836_45967998 | 5.96 |
Tdrd7 |
tudor domain containing 7 |
2583 |
0.3 |
chr11_7197480_7197826 | 5.95 |
Igfbp1 |
insulin-like growth factor binding protein 1 |
129 |
0.96 |
chr12_113987570_113987864 | 5.95 |
Gm37961 |
predicted gene, 37961 |
18865 |
0.14 |
chr3_153840565_153840726 | 5.94 |
Asb17 |
ankyrin repeat and SOCS box-containing 17 |
3564 |
0.13 |
chr6_143152541_143152739 | 5.92 |
Gm31108 |
predicted gene, 31108 |
1291 |
0.37 |
chr5_148777254_148777431 | 5.92 |
4930505K14Rik |
RIKEN cDNA 4930505K14 gene |
621 |
0.67 |
chr3_79378110_79378408 | 5.90 |
Gm17359 |
predicted gene, 17359 |
32880 |
0.17 |
chr1_133452688_133453146 | 5.86 |
Sox13 |
SRY (sex determining region Y)-box 13 |
28540 |
0.16 |
chr8_123642177_123642441 | 5.85 |
Rhou |
ras homolog family member U |
11620 |
0.03 |
chr11_75439481_75439671 | 5.84 |
Serpinf2 |
serine (or cysteine) peptidase inhibitor, clade F, member 2 |
2 |
0.94 |
chr10_33945506_33945695 | 5.83 |
Zup1 |
zinc finger containing ubiquitin peptidase 1 |
4260 |
0.13 |
chr5_121736830_121737005 | 5.83 |
Gm42866 |
predicted gene 42866 |
5500 |
0.12 |
chr15_25942411_25942580 | 5.83 |
Retreg1 |
reticulophagy regulator 1 |
184 |
0.95 |
chr11_113609690_113609845 | 5.82 |
Sstr2 |
somatostatin receptor 2 |
9575 |
0.17 |
chr14_122990850_122991017 | 5.81 |
Tmtc4 |
transmembrane and tetratricopeptide repeat containing 4 |
6898 |
0.22 |
chr1_184622020_184622382 | 5.81 |
Gm37800 |
predicted gene, 37800 |
4230 |
0.18 |
chr10_87329580_87329887 | 5.80 |
Gm23191 |
predicted gene, 23191 |
34413 |
0.16 |
chr17_80051656_80051839 | 5.78 |
Gpx4-ps1 |
glutathione peroxidase 4, pseudogene 1 |
2279 |
0.23 |
chr3_121903353_121903632 | 5.77 |
Gm42593 |
predicted gene 42593 |
40650 |
0.12 |
chrX_35957374_35957532 | 5.76 |
Dock11 |
dedicator of cytokinesis 11 |
10056 |
0.25 |
chr1_151130201_151130735 | 5.73 |
Gm8941 |
predicted gene 8941 |
6039 |
0.13 |
chr3_107949519_107949837 | 5.72 |
Gm12494 |
predicted gene 12494 |
3443 |
0.09 |
chr10_110707462_110707627 | 5.70 |
E2f7 |
E2F transcription factor 7 |
37895 |
0.16 |
chr14_34275354_34275514 | 5.69 |
Shld2 |
shieldin complex subunit 2 |
1175 |
0.29 |
chr6_95652897_95653066 | 5.68 |
Suclg2 |
succinate-Coenzyme A ligase, GDP-forming, beta subunit |
4487 |
0.36 |
chr5_146974799_146974984 | 5.67 |
Mtif3 |
mitochondrial translational initiation factor 3 |
11091 |
0.17 |
chr13_28662344_28662520 | 5.66 |
Mir6368 |
microRNA 6368 |
48441 |
0.17 |
chr6_72743864_72744051 | 5.65 |
Gm37736 |
predicted gene, 37736 |
7957 |
0.16 |
chr3_89113148_89113310 | 5.65 |
Gm29704 |
predicted gene, 29704 |
3495 |
0.09 |
chr1_130822202_130822462 | 5.63 |
Gm15848 |
predicted gene 15848 |
1628 |
0.25 |
chr13_92846534_92846735 | 5.62 |
Mtx3 |
metaxin 3 |
1436 |
0.47 |
chr4_138920907_138921120 | 5.60 |
Otud3 |
OTU domain containing 3 |
7068 |
0.15 |
chr17_24355260_24355582 | 5.60 |
Abca3 |
ATP-binding cassette, sub-family A (ABC1), member 3 |
3319 |
0.12 |
chr14_116710512_116710738 | 5.58 |
Gm38045 |
predicted gene, 38045 |
39590 |
0.23 |
chr18_64325483_64325793 | 5.57 |
St8sia3os |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3, opposite strand |
8068 |
0.16 |
chr8_110792652_110792976 | 5.57 |
Il34 |
interleukin 34 |
1926 |
0.23 |
chr5_43789494_43789670 | 5.56 |
Gm43181 |
predicted gene 43181 |
3465 |
0.14 |
chr1_168708254_168708422 | 5.56 |
1700063I16Rik |
RIKEN cDNA 1700063I16 gene |
32456 |
0.25 |
chr1_168305612_168305798 | 5.56 |
Gm37524 |
predicted gene, 37524 |
31966 |
0.2 |
chr11_70713419_70713657 | 5.55 |
Mir6925 |
microRNA 6925 |
7548 |
0.08 |
chr11_107452533_107452722 | 5.52 |
Pitpnc1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
18072 |
0.11 |
chr12_110381296_110381622 | 5.51 |
Gm47195 |
predicted gene, 47195 |
56074 |
0.08 |
chr12_91929732_91929921 | 5.50 |
Rpl31-ps1 |
ribosomal protein L31, pseudogene 1 |
38553 |
0.11 |
chr19_38372543_38372709 | 5.50 |
Gm50155 |
predicted gene, 50155 |
12888 |
0.14 |
chr7_98178942_98179132 | 5.46 |
Capn5 |
calpain 5 |
763 |
0.53 |
chr11_31001740_31002153 | 5.46 |
Gm12102 |
predicted gene 12102 |
1952 |
0.3 |
chr8_75350325_75350476 | 5.45 |
Umpk-ps |
uridine monophosphate kinase, pseudogene |
33402 |
0.12 |
chr17_13548106_13548274 | 5.45 |
Gm26375 |
predicted gene, 26375 |
14021 |
0.13 |
chr3_122059023_122059192 | 5.45 |
Abca4 |
ATP-binding cassette, sub-family A (ABC1), member 4 |
12531 |
0.17 |
chr14_29996020_29996356 | 5.45 |
Il17rb |
interleukin 17 receptor B |
2271 |
0.17 |
chr15_34493251_34493646 | 5.44 |
Rida |
reactive intermediate imine deaminase A homolog |
1723 |
0.21 |
chr19_26754124_26754675 | 5.44 |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
799 |
0.69 |
chr6_63550395_63550574 | 5.43 |
Gm44071 |
predicted gene, 44071 |
222043 |
0.02 |
chr18_67765309_67765869 | 5.42 |
Gm26910 |
predicted gene, 26910 |
9268 |
0.15 |
chr6_72961723_72961891 | 5.41 |
Tmsb10 |
thymosin, beta 10 |
3059 |
0.2 |
chr7_73882661_73882812 | 5.40 |
Mir7234 |
microRNA 7234 |
63146 |
0.07 |
chr13_66963580_66963762 | 5.39 |
Ptdss1 |
phosphatidylserine synthase 1 |
13096 |
0.1 |
chr17_34979579_34979759 | 5.38 |
Gm10501 |
predicted gene 10501 |
2119 |
0.08 |
chr3_27729149_27729300 | 5.38 |
Fndc3b |
fibronectin type III domain containing 3B |
17917 |
0.26 |
chr2_50355934_50356085 | 5.37 |
Gm48908 |
predicted gene 48908 |
24391 |
0.18 |
chr18_21372400_21372792 | 5.36 |
Gm22886 |
predicted gene, 22886 |
8335 |
0.2 |
chr10_115349642_115349806 | 5.35 |
Tmem19 |
transmembrane protein 19 |
660 |
0.63 |
chr8_124343978_124344300 | 5.35 |
Gm15775 |
predicted gene 15775 |
12344 |
0.14 |
chr15_28141421_28141577 | 5.34 |
Gm49233 |
predicted gene, 49233 |
13963 |
0.16 |
chr1_105687189_105687363 | 5.34 |
Relch |
RAB11 binding and LisH domain, coiled-coil and HEAT repeat containing |
9314 |
0.15 |
chr16_31993417_31993575 | 5.34 |
Hmgb1-ps6 |
high mobility group box 1, pseudogene 6 |
1628 |
0.18 |
chr6_52183461_52183625 | 5.34 |
Gm29430 |
predicted gene 29430 |
182 |
0.59 |
chrX_164370721_164370872 | 5.33 |
Vegfd |
vascular endothelial growth factor D |
2582 |
0.28 |
chr19_54200091_54200251 | 5.33 |
Gm50187 |
predicted gene, 50187 |
1780 |
0.47 |
chr17_80947685_80947878 | 5.33 |
Tmem178 |
transmembrane protein 178 |
3149 |
0.27 |
chr19_38134156_38134336 | 5.33 |
Pde6c |
phosphodiesterase 6C, cGMP specific, cone, alpha prime |
1300 |
0.38 |
chr15_100625793_100625948 | 5.31 |
Dazap2 |
DAZ associated protein 2 |
9538 |
0.08 |
chr8_114979772_114979943 | 5.29 |
Gm22556 |
predicted gene, 22556 |
73056 |
0.13 |
chr14_47016165_47016374 | 5.29 |
Samd4 |
sterile alpha motif domain containing 4 |
14904 |
0.15 |
chr8_36665899_36666062 | 5.27 |
Dlc1 |
deleted in liver cancer 1 |
52037 |
0.16 |
chr19_32628644_32628897 | 5.27 |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
8765 |
0.23 |
chr1_174742793_174742954 | 5.26 |
Fmn2 |
formin 2 |
28547 |
0.24 |
chr10_122343453_122343625 | 5.26 |
Gm36041 |
predicted gene, 36041 |
43353 |
0.16 |
chr10_7140427_7140586 | 5.26 |
Cnksr3 |
Cnksr family member 3 |
5000 |
0.3 |
chr14_22783164_22783347 | 5.25 |
Gm7473 |
predicted gene 7473 |
8011 |
0.31 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 11.2 | GO:0035564 | regulation of kidney size(GO:0035564) |
2.8 | 8.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
2.5 | 5.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.4 | 7.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.4 | 7.2 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
2.3 | 6.8 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
2.2 | 6.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.7 | 3.4 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
1.7 | 5.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.7 | 3.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.6 | 6.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.5 | 6.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.5 | 9.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
1.5 | 4.5 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.5 | 8.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.5 | 4.4 | GO:0015817 | histidine transport(GO:0015817) |
1.4 | 4.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.4 | 4.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.4 | 4.2 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
1.4 | 2.8 | GO:0046415 | urate metabolic process(GO:0046415) |
1.4 | 4.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
1.3 | 4.0 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.3 | 3.9 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
1.2 | 3.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.2 | 3.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
1.2 | 5.8 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.2 | 4.6 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.1 | 4.6 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.1 | 3.4 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
1.1 | 3.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.1 | 3.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.1 | 3.2 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
1.1 | 7.5 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.0 | 5.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.0 | 3.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
1.0 | 3.0 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
1.0 | 2.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.0 | 2.9 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.0 | 3.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.9 | 2.8 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.9 | 3.8 | GO:0003166 | bundle of His development(GO:0003166) |
0.9 | 2.8 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.9 | 2.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.9 | 2.7 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.9 | 5.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.9 | 0.9 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.9 | 5.3 | GO:0001705 | ectoderm formation(GO:0001705) |
0.9 | 2.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.9 | 2.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.9 | 2.6 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.9 | 2.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.8 | 6.8 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.8 | 3.4 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.8 | 4.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.8 | 2.5 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.8 | 0.8 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.8 | 2.5 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.8 | 2.5 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.8 | 2.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.8 | 3.2 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.8 | 3.2 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.8 | 10.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.8 | 1.6 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.8 | 3.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.8 | 2.4 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.8 | 3.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.8 | 3.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.8 | 2.3 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.8 | 3.0 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.8 | 2.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.8 | 1.5 | GO:0010159 | specification of organ position(GO:0010159) |
0.7 | 2.2 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.7 | 2.2 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.7 | 2.2 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.7 | 0.7 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.7 | 15.1 | GO:0051180 | vitamin transport(GO:0051180) |
0.7 | 3.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.7 | 3.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.7 | 5.5 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.7 | 2.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.7 | 3.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.7 | 1.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.7 | 2.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.7 | 3.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.7 | 2.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.7 | 2.0 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.7 | 0.7 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.7 | 2.0 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.6 | 1.3 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.6 | 2.6 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.6 | 0.6 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.6 | 1.9 | GO:0051917 | regulation of fibrinolysis(GO:0051917) |
0.6 | 1.9 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 0.6 | GO:0035483 | gastric emptying(GO:0035483) |
0.6 | 2.5 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.6 | 1.9 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.6 | 1.9 | GO:0090148 | membrane fission(GO:0090148) |
0.6 | 3.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.6 | 1.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.6 | 2.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.6 | 2.4 | GO:0046618 | drug export(GO:0046618) |
0.6 | 1.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.6 | 1.8 | GO:0097503 | sialylation(GO:0097503) |
0.6 | 1.8 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.6 | 2.4 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.6 | 1.8 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.6 | 2.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.6 | 4.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.6 | 5.8 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.6 | 2.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.6 | 1.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.6 | 6.9 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.6 | 1.7 | GO:0019532 | oxalate transport(GO:0019532) |
0.6 | 1.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.6 | 1.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.6 | 0.6 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.6 | 3.9 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.6 | 2.8 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.5 | 3.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.5 | 2.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.5 | 1.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.5 | 1.6 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.5 | 1.6 | GO:0002034 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.5 | 0.5 | GO:0048840 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
0.5 | 4.8 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.5 | 3.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.5 | 1.1 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.5 | 1.6 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.5 | 3.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.5 | 2.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.5 | 2.6 | GO:0046135 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.5 | 3.6 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.5 | 9.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.5 | 2.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.5 | 1.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.5 | 1.5 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.5 | 2.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 0.5 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.5 | 2.0 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.5 | 2.5 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.5 | 2.5 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.5 | 2.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 1.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.5 | 1.5 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.5 | 7.3 | GO:0051923 | sulfation(GO:0051923) |
0.5 | 1.0 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.5 | 1.9 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.5 | 1.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.5 | 1.0 | GO:1903416 | response to glycoside(GO:1903416) |
0.5 | 2.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.5 | 1.0 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.5 | 1.9 | GO:0008272 | sulfate transport(GO:0008272) |
0.5 | 1.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 5.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 1.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 1.9 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.5 | 1.4 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.5 | 0.5 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 0.9 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.5 | 4.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 1.8 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.5 | 0.5 | GO:0060594 | mammary gland specification(GO:0060594) |
0.5 | 1.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 0.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.5 | 1.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.5 | 1.4 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.5 | 1.4 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.5 | 0.9 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.5 | 2.7 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.4 | 2.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.4 | 1.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.4 | 0.4 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.4 | 1.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 1.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.4 | 0.9 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.4 | 2.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.4 | 1.3 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.4 | 1.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 1.7 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.4 | 1.3 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.4 | 2.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.4 | 1.7 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.4 | 0.4 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.4 | 0.4 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.4 | 2.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.4 | 2.5 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 1.3 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.4 | 1.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.4 | 2.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.4 | 1.7 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.4 | 1.2 | GO:0008355 | olfactory learning(GO:0008355) |
0.4 | 0.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 4.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 3.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.4 | 3.6 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.4 | 2.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.4 | 0.8 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 0.8 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.4 | 1.6 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.4 | 2.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.4 | 0.4 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.4 | 5.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.4 | 2.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 4.8 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 2.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 2.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.4 | 0.8 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.4 | 0.8 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.4 | 1.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.4 | 2.4 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.4 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.4 | 1.6 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.4 | 1.6 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.4 | 1.5 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 1.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.4 | 1.5 | GO:0090009 | primitive streak formation(GO:0090009) |
0.4 | 1.5 | GO:1901660 | calcium ion export(GO:1901660) |
0.4 | 1.1 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.4 | 10.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.4 | 1.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.4 | 0.8 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.4 | 0.4 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.4 | 1.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.4 | 2.6 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.4 | 1.5 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.4 | 0.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.4 | 0.7 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.4 | 1.5 | GO:0009597 | detection of virus(GO:0009597) |
0.4 | 1.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.4 | 0.7 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.4 | 1.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.4 | 1.8 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.4 | 1.1 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.4 | 0.7 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.4 | 1.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.4 | 1.8 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 2.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.4 | 2.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 1.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.4 | 1.1 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.4 | 1.1 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.4 | 1.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 1.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 1.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 1.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.3 | 0.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.3 | 6.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.3 | 1.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 0.3 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.3 | 11.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.3 | 2.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 2.7 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.3 | 1.4 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.3 | 4.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 1.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.3 | 1.0 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.3 | 0.7 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 1.0 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 1.0 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 2.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.3 | 1.0 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.3 | 1.6 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.3 | 1.0 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.3 | 3.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 1.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 0.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 2.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.3 | 0.3 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 0.6 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.3 | 1.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.3 | 0.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.3 | 1.6 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.3 | 0.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.3 | 6.0 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.3 | 1.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.3 | 0.6 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.3 | 0.6 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 0.3 | GO:2000468 | neutrophil aggregation(GO:0070488) regulation of peroxidase activity(GO:2000468) |
0.3 | 0.6 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.3 | 0.9 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 0.3 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.3 | 0.3 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.3 | 1.6 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.3 | 1.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 3.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 1.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 1.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 0.9 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.3 | 2.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.3 | 0.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 1.8 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.3 | 1.2 | GO:0033622 | integrin activation(GO:0033622) |
0.3 | 2.7 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.3 | 1.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 1.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.3 | 0.6 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.3 | 0.6 | GO:0070836 | caveola assembly(GO:0070836) |
0.3 | 0.6 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.3 | 1.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 2.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.3 | 1.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 0.6 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.3 | 2.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 0.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 3.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 1.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.3 | 1.8 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.3 | 1.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 0.9 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.3 | 2.7 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.3 | 4.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 2.6 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 0.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.3 | 0.6 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 0.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 1.2 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.3 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.3 | 0.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.3 | 0.9 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.3 | 4.0 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.3 | 0.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 0.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 2.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.3 | 0.3 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.3 | 0.6 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.3 | 2.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 0.8 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 0.6 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.3 | 1.7 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.3 | 1.4 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.3 | 1.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.3 | 1.7 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.3 | 0.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.3 | 0.5 | GO:2001171 | regulation of ATP biosynthetic process(GO:2001169) positive regulation of ATP biosynthetic process(GO:2001171) |
0.3 | 1.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 3.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.3 | 0.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 1.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 0.5 | GO:0000087 | mitotic M phase(GO:0000087) |
0.3 | 0.5 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.3 | 0.8 | GO:0007343 | egg activation(GO:0007343) |
0.3 | 1.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.3 | 0.3 | GO:0032364 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
0.3 | 0.3 | GO:0034311 | diol metabolic process(GO:0034311) |
0.3 | 0.5 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.3 | 0.8 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 1.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.3 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 2.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 1.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.3 | 2.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 3.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 0.3 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.3 | 0.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 0.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.3 | 0.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 1.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.3 | 0.8 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.8 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 0.5 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 0.3 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.3 | 2.0 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.3 | 2.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.3 | 2.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.3 | 0.3 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.3 | 2.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.3 | 1.8 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.3 | 2.8 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.7 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 1.0 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.5 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.2 | 1.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 1.2 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.2 | 0.7 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.2 | 1.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 0.2 | GO:0071072 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) negative regulation of phospholipid biosynthetic process(GO:0071072) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.2 | 0.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.7 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.2 | 1.0 | GO:0010878 | cholesterol storage(GO:0010878) |
0.2 | 3.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 2.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 0.2 | GO:0009750 | response to fructose(GO:0009750) |
0.2 | 1.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 1.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.7 | GO:0034093 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 1.9 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.2 | 0.7 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 0.2 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.2 | 0.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 1.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.7 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.2 | 0.9 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 0.9 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.2 | 0.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 3.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 4.4 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 1.4 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 5.5 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.2 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.7 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.2 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.2 | 0.7 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 0.5 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 1.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 1.1 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 6.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 0.7 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 3.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.4 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.2 | 0.2 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 0.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 1.7 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 0.4 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.2 | 0.4 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 0.6 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.2 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.6 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.2 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 1.5 | GO:0031579 | membrane raft organization(GO:0031579) |
0.2 | 6.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.9 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 0.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 0.9 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 1.3 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.2 | 0.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 1.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 1.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.6 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.2 | 0.4 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.2 | 1.5 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.2 | 2.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 17.8 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.2 | 4.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 1.4 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 0.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 0.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 0.2 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 0.2 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.2 | 0.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.2 | 0.6 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 0.4 | GO:0072179 | nephric duct formation(GO:0072179) |
0.2 | 5.1 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.2 | 3.1 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.6 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 0.8 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 0.6 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 1.8 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 1.6 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.2 | 0.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.2 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 0.8 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.2 | 0.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 3.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 0.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 0.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.2 | 0.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 1.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.8 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.2 | 1.6 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 0.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 1.8 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.6 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.2 | 0.2 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.2 | 1.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.4 | GO:0002432 | granuloma formation(GO:0002432) |
0.2 | 0.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 3.5 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.2 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 1.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.8 | GO:0046113 | purine nucleobase catabolic process(GO:0006145) nucleobase catabolic process(GO:0046113) |
0.2 | 2.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 0.2 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.2 | 1.0 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.2 | 0.6 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 0.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 1.9 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.2 | 3.0 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.8 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 1.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.2 | 1.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 2.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 0.4 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.2 | 0.9 | GO:0002591 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.2 | 1.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 1.5 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 2.8 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 0.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 0.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 0.4 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.2 | 0.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 0.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 3.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.2 | 1.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 0.2 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.2 | 1.6 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.2 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.2 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.2 | 0.4 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 1.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.2 | 2.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 0.5 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.2 | 1.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 0.2 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.2 | 0.5 | GO:0045821 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.2 | 0.4 | GO:0033080 | immature T cell proliferation(GO:0033079) immature T cell proliferation in thymus(GO:0033080) |
0.2 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 1.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.2 | 0.5 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.5 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 0.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 1.6 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.4 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
0.2 | 0.7 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 7.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.2 | 0.2 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.2 | 1.0 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 1.4 | GO:0021554 | optic nerve development(GO:0021554) |
0.2 | 4.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 0.5 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.2 | 0.3 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.2 | 0.5 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.2 | 0.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 1.6 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 1.0 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.2 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.2 | 1.0 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 0.5 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.2 | 0.2 | GO:0071029 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.2 | 0.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 2.4 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.2 | 0.3 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
0.2 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 1.0 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.2 | 0.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.2 | 0.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 1.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 0.2 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.2 | 1.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 1.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.2 | 0.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 0.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 0.7 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 0.2 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.2 | 0.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 0.7 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 1.0 | GO:0001893 | maternal placenta development(GO:0001893) |
0.2 | 4.8 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.2 | 0.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.2 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 0.2 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.2 | 0.5 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.2 | 0.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.5 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 0.5 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 0.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 0.3 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.2 | 0.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 1.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 0.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.6 | GO:0060281 | regulation of oocyte development(GO:0060281) |
0.2 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.5 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.2 | 0.5 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 5.6 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 0.5 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.2 | 0.5 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 5.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.2 | 0.6 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 1.1 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.2 | 0.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 0.6 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.3 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 0.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 0.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.5 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 0.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 0.3 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 1.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.3 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 | 0.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.6 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 0.6 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.2 | 0.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.5 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 2.8 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.2 | 0.5 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.8 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 1.1 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.2 | 0.2 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.2 | 0.8 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 1.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 4.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.2 | 1.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 0.9 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.2 | 0.5 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.2 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.2 | 0.2 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.2 | 0.6 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.6 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.3 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.3 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.7 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 0.6 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 4.1 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 1.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 1.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.4 | GO:0032817 | regulation of natural killer cell proliferation(GO:0032817) |
0.1 | 1.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.6 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 3.0 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 1.3 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 1.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.8 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.3 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 0.6 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 1.0 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.1 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 1.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 1.8 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 1.3 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.3 | GO:0031508 | chromatin remodeling at centromere(GO:0031055) pericentric heterochromatin assembly(GO:0031508) |
0.1 | 0.6 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 0.3 | GO:2000351 | regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 1.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.3 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.1 | 0.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.8 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.3 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.3 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.4 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.1 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.1 | 0.3 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.8 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.7 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.7 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.1 | 0.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.5 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.1 | 0.9 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.4 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.3 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 4.4 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.4 | GO:0009155 | dGTP catabolic process(GO:0006203) purine deoxyribonucleotide catabolic process(GO:0009155) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.1 | 0.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 1.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.1 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.4 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.8 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.3 | GO:0070293 | renal absorption(GO:0070293) |
0.1 | 1.7 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 2.2 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.1 | 0.6 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.5 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
0.1 | 1.0 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 2.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.9 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 2.0 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 1.3 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.6 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.1 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.3 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.1 | 0.3 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 0.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.6 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 1.0 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.1 | 2.1 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 1.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.1 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.1 | GO:0070668 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.6 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.4 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.7 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.1 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.1 | 0.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.1 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.1 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 2.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.4 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 1.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.2 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 0.1 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 0.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 1.2 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 1.2 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.4 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.6 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.1 | 0.5 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 2.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 0.5 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.8 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
0.1 | 0.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 1.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 1.2 | GO:0051292 | pore complex assembly(GO:0046931) nuclear pore complex assembly(GO:0051292) |
0.1 | 0.8 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.1 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.3 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 0.3 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.5 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.1 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.1 | 1.8 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.3 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.1 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.1 | 0.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.5 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.1 | 0.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.5 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.4 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.1 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 3.1 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.1 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 0.6 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.9 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 1.7 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.6 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.1 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.1 | 0.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 1.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.2 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.8 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 3.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.9 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.3 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.2 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.1 | 0.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 1.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.1 | 0.8 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 1.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.1 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.1 | 0.3 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.6 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.1 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.3 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.3 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.1 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.1 | 5.9 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.1 | 0.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.5 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 1.1 | GO:0014904 | myotube cell development(GO:0014904) |
0.1 | 1.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.5 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 1.8 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.9 | GO:0031929 | TOR signaling(GO:0031929) |
0.1 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.8 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.4 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.5 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 1.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.5 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.2 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
0.1 | 0.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.2 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.1 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.3 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.1 | 0.1 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.1 | 0.9 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.3 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.2 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.3 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.2 | GO:0003160 | endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.1 | 1.0 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.2 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.1 | 0.7 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.7 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.8 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.6 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.2 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.1 | 0.2 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.1 | 1.0 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.4 | GO:0035878 | nail development(GO:0035878) |
0.1 | 1.3 | GO:0031279 | regulation of cyclase activity(GO:0031279) |
0.1 | 0.7 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 0.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.1 | 0.1 | GO:1900024 | regulation of substrate adhesion-dependent cell spreading(GO:1900024) |
0.1 | 0.7 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 5.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.1 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 1.1 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.8 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 1.6 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 1.2 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 1.5 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.9 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.5 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.5 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.5 | GO:0043482 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.3 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.4 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.3 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.4 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.1 | 0.4 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.9 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 1.2 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 1.0 | GO:0042761 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 4.9 | GO:0007599 | hemostasis(GO:0007599) coagulation(GO:0050817) |
0.1 | 1.0 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 1.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.1 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.1 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 3.7 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 0.2 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.1 | 0.9 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 1.2 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.2 | GO:0038107 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.1 | 0.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.2 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.6 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.3 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.3 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.6 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 1.1 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.2 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 0.7 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.1 | 1.0 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 1.4 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.1 | 0.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.2 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.4 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.7 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.4 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.1 | 2.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 1.1 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.2 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.4 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.1 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 1.0 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.1 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.2 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 5.7 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.3 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.3 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 0.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.1 | 0.2 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.5 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 2.6 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.1 | 0.8 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.2 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) positive regulation of enamel mineralization(GO:0070175) |
0.1 | 1.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 1.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.2 | GO:0015908 | fatty acid transport(GO:0015908) |
0.1 | 0.3 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.1 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.8 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 1.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.2 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 1.6 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.2 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 0.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.1 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.3 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.2 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
0.1 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.1 | GO:0071599 | otic vesicle development(GO:0071599) |
0.1 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.6 | GO:0048747 | muscle fiber development(GO:0048747) |
0.1 | 0.1 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.1 | 0.1 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.1 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.7 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.8 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.1 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.5 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.1 | 0.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 0.4 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 1.3 | GO:0050881 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.1 | 1.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.1 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.1 | 0.1 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
0.1 | 0.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.1 | GO:0009204 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
0.1 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.1 | 0.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.4 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.3 | GO:2000756 | regulation of histone acetylation(GO:0035065) regulation of peptidyl-lysine acetylation(GO:2000756) |
0.1 | 0.3 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 1.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.8 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.1 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.5 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.3 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.3 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.1 | 0.2 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.1 | 2.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.2 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.3 | GO:0050931 | pigment cell differentiation(GO:0050931) |
0.1 | 0.1 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.2 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.1 | 0.3 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.1 | 0.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.1 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.1 | 0.5 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.3 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.1 | 0.1 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) |
0.1 | 0.1 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.1 | 0.3 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.3 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 0.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 0.9 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.1 | 0.8 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.2 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 1.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.1 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.1 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 1.9 | GO:0048017 | inositol lipid-mediated signaling(GO:0048017) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.1 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.2 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.2 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 1.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.5 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.1 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.4 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.1 | 0.1 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 0.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 2.1 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 1.4 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.7 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.2 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.1 | 1.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0009415 | response to water(GO:0009415) |
0.1 | 0.3 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.1 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.1 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.3 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.1 | 0.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.3 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.2 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 0.2 | GO:0035247 | peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.8 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.8 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.1 | 0.9 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.1 | 0.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.2 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 0.2 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.1 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.1 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 0.4 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.2 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.2 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.1 | 0.1 | GO:0042749 | circadian sleep/wake cycle process(GO:0022410) regulation of circadian sleep/wake cycle(GO:0042749) |
0.1 | 0.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.3 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.1 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.6 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.1 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.1 | 0.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 2.4 | GO:0006821 | chloride transport(GO:0006821) |
0.1 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.1 | GO:0072319 | clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
0.1 | 0.2 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.1 | 0.2 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 4.7 | GO:0042384 | cilium assembly(GO:0042384) |
0.1 | 0.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.4 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.1 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.1 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.1 | 0.1 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.1 | 1.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.1 | GO:0030431 | sleep(GO:0030431) |
0.1 | 1.3 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.1 | GO:0006901 | vesicle coating(GO:0006901) |
0.0 | 0.0 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.1 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.0 | 0.4 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.0 | 0.3 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.0 | 0.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.1 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.0 | 0.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.9 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 1.5 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 0.4 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.7 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.0 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.0 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.0 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.0 | 0.0 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.0 | 0.0 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.0 | 3.0 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.1 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.0 | 2.6 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.0 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.0 | 0.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.0 | GO:0048242 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.0 | 0.8 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.0 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.0 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.0 | 0.2 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.3 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.8 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 0.8 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.2 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.0 | 0.1 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.1 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 2.4 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.1 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.5 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.3 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 2.3 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.6 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.0 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.0 | 0.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 1.3 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.0 | 0.0 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.0 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.0 | 2.3 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 0.1 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.3 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.0 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.0 | 0.2 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.3 | GO:0051236 | establishment of RNA localization(GO:0051236) |
0.0 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 1.0 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.1 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.1 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.0 | 0.0 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.0 | 0.8 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.0 | GO:0046530 | photoreceptor cell differentiation(GO:0046530) |
0.0 | 0.2 | GO:0035304 | regulation of protein dephosphorylation(GO:0035304) |
0.0 | 0.0 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.0 | GO:0042161 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.0 | 0.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.0 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.0 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.0 | 0.1 | GO:0050779 | RNA destabilization(GO:0050779) |
0.0 | 0.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.0 | 0.2 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.8 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.0 | 0.1 | GO:0048041 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.0 | 0.1 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.0 | 0.0 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.1 | GO:0050433 | regulation of catecholamine secretion(GO:0050433) |
0.0 | 0.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.3 | GO:0030203 | glycosaminoglycan metabolic process(GO:0030203) |
0.0 | 0.3 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.3 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.5 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.0 | 0.2 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 0.0 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.2 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.2 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.1 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 2.8 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.0 | 0.3 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.2 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.0 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.0 | GO:0060592 | mammary gland formation(GO:0060592) |
0.0 | 0.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) |
0.0 | 0.0 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.0 | 0.0 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
0.0 | 0.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.0 | 0.1 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.0 | 0.0 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.2 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.0 | 0.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.1 | GO:0045141 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic telomere clustering(GO:0045141) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0015844 | monoamine transport(GO:0015844) |
0.0 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.3 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.0 | 0.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.0 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.0 | 0.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
0.0 | 0.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.0 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 0.0 | GO:0044838 | cell quiescence(GO:0044838) |
0.0 | 0.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 1.9 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 0.0 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.1 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.0 | 0.1 | GO:0060039 | pericardium development(GO:0060039) |
0.0 | 0.5 | GO:0044782 | cilium organization(GO:0044782) |
0.0 | 0.2 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.0 | GO:0033194 | response to hydroperoxide(GO:0033194) cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.0 | 0.0 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.2 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.0 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.0 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.0 | 0.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.0 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.0 | 0.0 | GO:0009620 | response to fungus(GO:0009620) |
0.0 | 0.1 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.0 | 0.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.0 | 0.2 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.2 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.3 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.0 | 0.2 | GO:0008016 | regulation of heart contraction(GO:0008016) |
0.0 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.0 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.0 | 0.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.0 | 0.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.0 | 0.0 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 1.5 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.0 | 0.1 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) |
0.0 | 0.0 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.1 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.1 | GO:0045191 | regulation of isotype switching(GO:0045191) |
0.0 | 0.2 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.0 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
0.0 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.1 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.0 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.0 | 0.0 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.1 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.0 | 0.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.0 | 0.0 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.4 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.0 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.0 | 0.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.0 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.2 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 | 0.1 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 0.1 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.1 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.1 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.0 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.0 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.0 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.1 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.0 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.0 | GO:0002885 | positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) positive regulation of hypersensitivity(GO:0002885) |
0.0 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.0 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.0 | 0.1 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.8 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.0 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
0.0 | 0.0 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.3 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.0 | 0.1 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.0 | 0.0 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.0 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.0 | 0.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.0 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.0 | 0.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.0 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.0 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.0 | 0.0 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.0 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.0 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.1 | GO:0098534 | centriole assembly(GO:0098534) |
0.0 | 0.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.4 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0097553 | calcium ion transmembrane import into cytosol(GO:0097553) calcium ion import into cytosol(GO:1902656) |
0.0 | 0.0 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.0 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.0 | 0.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.0 | 0.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.0 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.0 | 0.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.0 | 0.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.0 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.0 | GO:0010658 | striated muscle cell apoptotic process(GO:0010658) |
0.0 | 0.0 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.0 | GO:0048563 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic organ morphogenesis(GO:0048563) |
0.0 | 0.0 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.0 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.0 | 0.0 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.0 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.0 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.0 | 0.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.0 | GO:0002702 | positive regulation of production of molecular mediator of immune response(GO:0002702) |
0.0 | 0.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.0 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.0 | 0.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.0 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.0 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.1 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.0 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.0 | 0.9 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.0 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.0 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.0 | 0.0 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.0 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.0 | 0.0 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.0 | 0.0 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.0 | 0.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.1 | GO:0071242 | response to ammonium ion(GO:0060359) cellular response to ammonium ion(GO:0071242) |
0.0 | 0.0 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 14.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.7 | 5.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.5 | 4.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.4 | 4.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.2 | 7.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.0 | 3.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.0 | 7.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.9 | 3.8 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.9 | 2.8 | GO:0031417 | NatC complex(GO:0031417) |
0.8 | 4.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.8 | 2.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.8 | 2.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.7 | 0.7 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.7 | 2.7 | GO:0031983 | vesicle lumen(GO:0031983) |
0.7 | 3.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.7 | 6.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.6 | 2.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.6 | 1.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.6 | 6.3 | GO:0042627 | chylomicron(GO:0042627) |
0.6 | 3.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.6 | 3.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.6 | 3.4 | GO:0002177 | manchette(GO:0002177) |
0.6 | 2.2 | GO:0097433 | dense body(GO:0097433) |
0.5 | 1.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.5 | 3.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.5 | 3.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.5 | 3.9 | GO:0045179 | apical cortex(GO:0045179) |
0.5 | 1.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.5 | 1.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 3.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.5 | 1.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 0.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 6.5 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 1.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.5 | 1.8 | GO:1990130 | Iml1 complex(GO:1990130) |
0.4 | 3.1 | GO:0045180 | basal cortex(GO:0045180) |
0.4 | 1.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.4 | 0.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.4 | 2.2 | GO:0005767 | secondary lysosome(GO:0005767) |
0.4 | 1.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 1.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.4 | 2.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 3.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 4.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.4 | 1.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.4 | 1.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 2.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 0.4 | GO:0016342 | catenin complex(GO:0016342) |
0.4 | 3.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 4.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 1.4 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.3 | 1.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 0.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 3.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 0.7 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 1.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 1.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 1.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 1.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.3 | 5.7 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 6.7 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 1.3 | GO:0030689 | Noc complex(GO:0030689) |
0.3 | 0.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 0.6 | GO:0098793 | presynapse(GO:0098793) |
0.3 | 3.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 1.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 3.0 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 1.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.3 | 4.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 8.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 4.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 5.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 1.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 1.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.3 | 2.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 26.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 2.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 0.6 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 1.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.3 | 5.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.3 | 1.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 2.7 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 0.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.3 | 3.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 1.3 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 2.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 1.0 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 0.8 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 1.8 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 6.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 1.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 1.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 3.2 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 1.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 0.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 1.2 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 0.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 1.2 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 1.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 0.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.2 | 4.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 1.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 2.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 6.5 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 0.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 0.9 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 1.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 0.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 1.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 0.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 2.5 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 1.9 | GO:0031430 | M band(GO:0031430) |
0.2 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 0.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 0.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 2.6 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 1.6 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 1.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 9.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 1.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 3.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 1.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 1.9 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 1.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 1.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 3.8 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 2.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.3 | GO:0031252 | cell leading edge(GO:0031252) |
0.2 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 7.2 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 2.2 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 1.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 3.4 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.2 | 0.2 | GO:0001939 | female pronucleus(GO:0001939) |
0.2 | 0.5 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 1.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 9.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 1.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 15.5 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.2 | 0.2 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 0.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 2.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.7 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 0.2 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 0.2 | GO:0097458 | neuron part(GO:0097458) |
0.2 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 0.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 1.1 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 1.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 0.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 1.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 7.2 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 8.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 0.8 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 3.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 3.2 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.2 | 0.6 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 0.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 7.2 | GO:0005903 | brush border(GO:0005903) |
0.1 | 7.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.7 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 1.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 16.7 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 4.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 2.4 | GO:0030424 | axon(GO:0030424) |
0.1 | 42.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 3.5 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.4 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 1.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 1.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 10.4 | GO:0030496 | midbody(GO:0030496) |
0.1 | 3.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 27.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 8.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 1.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 2.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 2.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 16.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 31.6 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 1.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 2.1 | GO:0012505 | endomembrane system(GO:0012505) |
0.1 | 2.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 2.9 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 6.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 1.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 0.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 1.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 2.0 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 9.4 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 5.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 11.4 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 2.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.6 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 1.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.5 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 1.1 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 5.1 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.4 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 3.6 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 3.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 1.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 3.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.8 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 1.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.2 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 8.3 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 1.2 | GO:0043227 | membrane-bounded organelle(GO:0043227) |
0.1 | 2.3 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 1.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.2 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 1.1 | GO:0045202 | synapse(GO:0045202) |
0.1 | 84.0 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 7.6 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 2.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 3.0 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 2.6 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 1.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.2 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 1.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.1 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.1 | 1.5 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.3 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 1.0 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 1.0 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 8.1 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 7.1 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 1.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.9 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 1.0 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 2.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 1.3 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 1.1 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.4 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 2.5 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.4 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 3.2 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 1.9 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 4.4 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 15.5 | GO:0030054 | cell junction(GO:0030054) |
0.1 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 2.0 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.8 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.6 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 3.0 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.2 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 1.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 2.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.9 | GO:0044452 | nucleolar part(GO:0044452) |
0.1 | 9.2 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.3 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 64.4 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.9 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.5 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.1 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.1 | 0.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 2.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.8 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 1.4 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 31.0 | GO:0005856 | cytoskeleton(GO:0005856) |
0.1 | 12.4 | GO:0005768 | endosome(GO:0005768) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.1 | GO:0031672 | A band(GO:0031672) |
0.1 | 2.1 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 1.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.4 | GO:0032991 | macromolecular complex(GO:0032991) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 7.7 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 2.5 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.1 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 87.6 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 0.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 8.2 | GO:0031982 | vesicle(GO:0031982) |
0.1 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.2 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 40.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 37.5 | GO:0005886 | plasma membrane(GO:0005886) |
0.0 | 107.1 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.9 | GO:0005773 | vacuole(GO:0005773) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 4.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 56.5 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 2.6 | GO:0005622 | intracellular(GO:0005622) |
0.0 | 0.1 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 28.4 | GO:0016020 | membrane(GO:0016020) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 6.8 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.9 | 5.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.8 | 7.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.6 | 4.8 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.6 | 4.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.4 | 4.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.3 | 4.0 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
1.2 | 3.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.2 | 1.2 | GO:0050692 | DBD domain binding(GO:0050692) |
1.2 | 3.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.2 | 7.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
1.2 | 7.0 | GO:0005499 | vitamin D binding(GO:0005499) |
1.1 | 3.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.0 | 3.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.0 | 1.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.0 | 4.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.0 | 6.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.9 | 9.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.9 | 2.7 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.9 | 2.7 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.9 | 1.8 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.9 | 2.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.9 | 1.7 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.9 | 3.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.9 | 2.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.8 | 2.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.8 | 2.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.8 | 3.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.8 | 3.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.8 | 2.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.8 | 6.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.8 | 11.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.8 | 3.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.8 | 3.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.8 | 3.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.7 | 2.2 | GO:0045340 | mercury ion binding(GO:0045340) |
0.7 | 2.2 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.7 | 11.2 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.7 | 1.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.7 | 3.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 3.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.7 | 2.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.6 | 3.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.6 | 1.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.6 | 2.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.6 | 3.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.6 | 2.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.6 | 1.9 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.6 | 1.9 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.6 | 2.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.6 | 1.8 | GO:0070905 | serine binding(GO:0070905) |
0.6 | 3.6 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.6 | 2.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.6 | 0.6 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.6 | 1.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.6 | 1.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.6 | 1.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.6 | 1.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.5 | 10.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.5 | 3.2 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.5 | 1.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.5 | 0.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 1.6 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 1.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 0.5 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.5 | 1.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 10.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.5 | 3.0 | GO:0002054 | nucleobase binding(GO:0002054) |
0.5 | 1.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.5 | 1.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.5 | 1.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.5 | 1.4 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 1.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 4.2 | GO:0052688 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.5 | 0.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.5 | 5.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.5 | 6.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.5 | 2.7 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.5 | 2.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.5 | 2.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 0.9 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.4 | 1.3 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.4 | 7.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 2.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 1.3 | GO:0035877 | death effector domain binding(GO:0035877) |
0.4 | 0.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.4 | 1.3 | GO:0019862 | IgA binding(GO:0019862) |
0.4 | 6.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.4 | 0.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 0.4 | GO:0035276 | ethanol binding(GO:0035276) |
0.4 | 1.3 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.4 | 3.7 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 5.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 1.2 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 28.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 2.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.4 | 0.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.4 | 6.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 1.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.4 | 1.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.4 | 1.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 1.6 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.4 | 5.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.4 | 3.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 0.4 | GO:0016918 | retinal binding(GO:0016918) |
0.4 | 1.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 2.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.4 | 4.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.4 | 1.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 3.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.4 | 1.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 1.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.4 | 0.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 13.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 2.6 | GO:0003896 | DNA primase activity(GO:0003896) |
0.4 | 1.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 1.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.4 | 5.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.4 | 1.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.4 | 2.8 | GO:0036122 | BMP binding(GO:0036122) |
0.4 | 2.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.3 | 1.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 1.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 1.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 6.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 1.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.3 | 1.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 0.3 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.3 | 1.0 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 1.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 1.7 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.3 | 1.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 1.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 2.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 1.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.3 | 1.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.3 | 1.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 1.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 0.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.3 | 1.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.3 | 2.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 0.6 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.3 | 9.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 0.9 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 1.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 1.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 0.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.3 | 13.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.3 | 5.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 0.9 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 4.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 0.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 0.9 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 5.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 1.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 5.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 4.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 0.9 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.3 | 3.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 1.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 7.6 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.3 | 0.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 1.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 3.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.3 | 1.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 1.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 0.8 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 3.0 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.3 | 0.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 0.8 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 0.8 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.3 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 4.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.3 | 5.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 1.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 0.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 3.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 22.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.3 | 0.8 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.3 | 0.8 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.3 | 1.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 1.0 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.3 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.3 | 1.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 1.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 1.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 0.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 2.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 2.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 2.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 2.2 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 1.0 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 1.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 1.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 1.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 2.1 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.2 | 0.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 6.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 1.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 2.3 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.2 | 1.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 0.7 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 7.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 0.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 0.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.2 | 0.5 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 0.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 0.7 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 0.5 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.2 | 0.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 0.4 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 1.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.9 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 3.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.7 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 11.2 | GO:0035326 | enhancer binding(GO:0035326) |
0.2 | 0.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 3.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 9.8 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 0.4 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 0.6 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 0.9 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 9.0 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.2 | 4.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.9 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 2.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.2 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.2 | 1.3 | GO:0018450 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 3.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 1.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 2.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 4.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 0.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 1.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 1.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 3.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 1.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 1.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 2.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 4.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 0.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.8 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 2.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 1.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 2.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 1.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 4.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 0.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 1.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.2 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.2 | 3.1 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.2 | 0.6 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.2 | 2.3 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 0.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 2.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.8 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 1.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 0.8 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 10.6 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.2 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 2.6 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 1.7 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 0.4 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 1.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.9 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 7.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 2.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 2.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 1.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 0.7 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 0.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.2 | 2.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 0.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 3.7 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 5.1 | GO:0019842 | vitamin binding(GO:0019842) |
0.2 | 2.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 1.1 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.2 | 0.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 1.4 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.2 | 0.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 5.0 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 1.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.2 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.2 | 0.5 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 4.5 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.2 | 0.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 1.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 0.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 31.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 0.8 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.2 | 2.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 10.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 0.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 0.7 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.2 | 2.0 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.2 | 1.5 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 1.0 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.2 | 1.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.3 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.2 | 0.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 1.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 1.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 0.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.6 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 4.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 1.1 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 0.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 0.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 5.8 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 0.6 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.2 | 0.3 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.2 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 2.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 4.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 0.3 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.2 | 0.3 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.2 | 0.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 0.5 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 0.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 1.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.7 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 4.0 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 5.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 11.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 1.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 1.0 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 1.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 1.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 5.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 2.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 1.7 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 1.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.1 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 0.8 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.5 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 0.4 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 10.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.3 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.5 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.9 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.7 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 2.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 13.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 1.2 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 2.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 3.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 1.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.5 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 2.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 1.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 1.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 3.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 2.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 8.2 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 2.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 1.5 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.1 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 2.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 1.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.5 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.1 | 1.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 1.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 4.1 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 4.1 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 1.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 3.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 2.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 2.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.2 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 1.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 1.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.4 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 1.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 1.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 1.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 8.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.6 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 1.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.6 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 1.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 3.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 15.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.1 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 1.7 | GO:0004115 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.3 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.1 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.2 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 1.6 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 0.2 | GO:1990446 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
0.1 | 0.1 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 4.4 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.1 | 1.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 1.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 3.7 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.8 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 3.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 1.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.6 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 1.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 3.5 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 1.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 1.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 3.5 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.9 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 1.4 | GO:0032813 | tumor necrosis factor receptor binding(GO:0005164) tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.1 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 12.0 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 5.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 1.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 4.3 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.9 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.1 | 1.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.1 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 2.2 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.1 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.8 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.4 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 5.8 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 2.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.4 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.4 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.3 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 1.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 1.5 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 1.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.2 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.1 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 1.8 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 1.1 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.2 | GO:0009975 | cyclase activity(GO:0009975) |
0.1 | 2.2 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 1.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.7 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 1.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 3.0 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.6 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 0.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.2 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.1 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.1 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.1 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.4 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 1.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) acetylcholine receptor inhibitor activity(GO:0030550) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 1.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 6.1 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 1.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.8 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 6.9 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 9.3 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 2.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 1.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 1.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.4 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.3 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 1.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.3 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 2.1 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 1.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 1.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 2.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 1.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 3.3 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 2.9 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.2 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.5 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.2 | GO:0018640 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) tocotrienol omega-hydroxylase activity(GO:0052872) thalianol hydroxylase activity(GO:0080014) |
0.1 | 9.2 | GO:0019904 | protein domain specific binding(GO:0019904) |
0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 5.9 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 1.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 24.7 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.1 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.3 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.0 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 0.0 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 1.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 1.1 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 0.1 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.3 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 1.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 1.8 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 2.9 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 5.4 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 3.2 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.0 | 1.7 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.0 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.0 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.7 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 1.4 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 1.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.0 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 0.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.3 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.0 | 0.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.9 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.0 | 0.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.3 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.3 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.1 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 0.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.1 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.3 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 3.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.0 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 7.1 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
0.0 | 0.0 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.0 | 0.4 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
0.0 | 0.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.6 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.2 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.0 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.0 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.0 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.0 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 8.8 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.2 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.0 | 4.3 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.0 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 2.2 | GO:0042803 | protein homodimerization activity(GO:0042803) |
0.0 | 0.1 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.0 | 0.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.0 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.0 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.0 | 0.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.0 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0017099 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.1 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.0 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.0 | GO:0001030 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.0 | 3.1 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 31.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.6 | 2.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.5 | 22.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 20.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.4 | 7.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 1.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 5.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 0.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 7.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 11.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 1.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 4.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 1.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 1.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 5.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 13.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 0.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 5.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 8.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 2.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 5.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 4.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 9.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 4.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 0.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 0.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 1.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 2.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 3.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 1.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 0.9 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 11.9 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 2.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 2.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 5.8 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 4.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 5.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 7.2 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 2.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 3.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 0.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 0.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 1.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 1.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 2.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 6.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 1.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 3.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 2.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 2.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 31.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 8.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 3.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 0.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 1.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 2.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 0.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 3.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 3.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 0.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 5.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 5.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 2.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 2.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 3.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 2.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 3.3 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 2.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 2.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 2.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 2.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 9.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 1.8 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 6.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 1.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 5.0 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 7.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.9 | 25.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.9 | 12.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.8 | 6.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.7 | 8.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.7 | 0.7 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.6 | 6.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.6 | 8.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.6 | 6.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.6 | 5.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.6 | 4.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.6 | 3.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 8.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 1.0 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.5 | 3.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.5 | 2.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.5 | 5.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.5 | 5.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.4 | 12.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 4.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 1.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.4 | 3.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 0.4 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.4 | 0.8 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.4 | 4.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 10.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.4 | 7.6 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.4 | 10.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.4 | 9.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 8.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 3.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 3.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 4.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 6.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 1.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 5.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 1.0 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.3 | 1.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 0.6 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.3 | 1.5 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 4.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 5.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 3.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 2.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 4.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 4.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 2.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 2.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 2.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 6.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 2.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 4.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 4.1 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.3 | 10.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 1.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 8.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 0.5 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.3 | 0.3 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.2 | 4.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 2.7 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 1.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 4.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 1.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 1.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 12.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 0.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 3.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 3.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 3.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 4.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 0.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 2.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 3.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 0.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 0.9 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 5.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 2.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 1.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 2.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 2.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 3.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 1.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 2.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 3.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 0.6 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 0.9 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.2 | 5.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 3.4 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 1.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 13.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 2.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 0.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 3.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 0.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 2.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 3.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 3.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 1.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 10.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 1.6 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 4.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 0.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 4.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 2.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 1.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 2.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 3.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.4 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 2.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 9.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 6.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 3.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 2.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 1.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 5.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 1.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 5.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.2 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 2.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.6 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 2.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 4.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 3.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.4 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 0.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 7.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.1 | 0.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 0.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.6 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 1.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.5 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.3 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 8.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 1.0 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.7 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.1 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 0.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.1 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 2.4 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 1.0 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 1.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 2.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 1.7 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.0 | 2.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.3 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 3.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 1.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.1 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.0 | 0.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.0 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
0.0 | 0.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.5 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 1.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.0 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |